ACG 2024
ACG 2024
Advertisement
Rob DillardACG 2024 | November 4, 2024
Upadacitinib (Rinvoq) therapy yields favorable outcomes in people with Crohn disease (CD).
Read More
Rob DillardACG 2024 | October 30, 2024
Patients with ulcerative colitis taking tofacitinib or biologics do not have an increased risk of MI or stroke.
Jordana JampelACG 2024 | October 29, 2024
The biosimilars were as effective in treating inflammatory bowel disease.
Advertisement
Advertisement
Advertisement
Latest News

November 4, 2024